Blood vessel plugging device

By designing a folded vascular closure device, the vascular puncture port is clamped with catheter and hemostasis, the problem of long hemostasis time after femoral intervention is solved, and the effect of faster hemostasis and relieve patient pain is achieved.

CN221997922UActive Publication Date: 2024-11-15DK MEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202420359992.6
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-02-27
Publication Date
2024-11-15
Estimated Expiration
2034-02-27

AI Technical Summary

Technical Problem

In the prior art, the hemostasis time at the puncture point after femoral intervention is long, which increases the labor force of medical staff and the pain of patients, and the manual compression method is not efficient enough.

Method used

A blood vessel closure device is designed, including a catheter, a first hemostasis member and a second hemostasis member. By pulling the traction line, the hemostasis member is folded and fits to the inner wall and outer surface of the blood vessel, clamps the blood vessel puncture port and prevents blood from being sprayed out. and biodegradable materials are used to reduce the risk of infection of indwellings.

Benefits of technology

It shortens the hemostasis time and bedtime, reduces the patient's pain and the intensity of medical care, and has a simple structure, convenient operation, and good sealing effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221997922U_ABST
    Figure CN221997922U_ABST
Patent Text Reader

Abstract

The utility model discloses a blood vessel plugging device which comprises a catheter, a first hemostasis piece, a first pull wire, a second hemostasis piece and a second pull wire. The catheter is provided with an inner cavity, and the first hemostasis piece is arranged at one end of the catheter. The first end of the first pull wire is fixed to the first hemostasis piece through the inner cavity, the second end of the first pull wire extends out of the inner cavity, and the first hemostasis piece is folded under pulling of the first pull wire to be attached to the inner wall of a blood vessel of a puncture part. The second hemostasis part is arranged in the inner cavity, the first end of the second traction line is fixed to the second hemostasis part through the inner cavity, the second end of the second traction line extends out of the inner cavity, and the second hemostasis part is folded under pulling of the second traction line to be attached to the outer surface of the blood vessel of the puncture part. According to the blood vessel plugging device, the hemostasis time and the bedridden time can be shortened, the pain of a patient and the strength of medical care are relieved, the structure is simple, operation is convenient, machining is easy, the first hemostasis piece and the second hemostasis piece are matched to plug the blood vessel puncture portion, and the plugging effect is good.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical devices, in particular to a blood vessel blocking device. Background Art

[0002] Percutaneous access to the vascular system for vascular device delivery is a common medical procedure. A hollow needle is typically used to puncture the blood vessel, and then an introducer sheath is introduced to open the puncture site for the introduction of a catheter and guidewire to guide through the vascular system to facilitate delivery. For example, in many cases, vascular access requires the introduction of a catheter and guidewire through the femoral artery. After the procedure is complete, the device is removed from the patient and pressure is applied to the puncture site to stop bleeding.

[0003] Manual compression hemostasis was used earlier to stop bleeding at the puncture point after femoral artery intervention. Manual compression hemostasis has been used clinically for a long time, but long-term compression hemostasis and bed rest increase the workload of medical staff on the one hand and the pain of patients on the other.

[0004] Therefore, how to provide a vascular occlusion device to shorten the hemostasis time and bed rest time, and reduce the patient's pain and the intensity of medical care is a technical problem that technicians in this field currently need to solve. Utility Model Content

[0005] In view of this, the purpose of the utility model is to provide a blood vessel occluding device to shorten the hemostasis time and bed rest time, and alleviate the patient's pain and the intensity of medical care.

[0006] In order to achieve the above purpose, the utility model provides the following technical solutions:

[0007] A blood vessel occlusion device, comprising:

[0008] a catheter having an inner lumen;

[0009] A first hemostatic member is arranged at one end of the catheter, the first hemostatic member is a tubular structure with one end closed and the other end open, and a hollow opening penetrating through the wall thickness is opened on the outer wall of the first hemostatic member, and a support leg is formed between two adjacent hollow openings, and the support leg can be folded when the two ends of the first hemostatic member are close to each other;

[0010] a first traction line, a first end of which is fixed to the first hemostatic member through the inner cavity, and a second end of which is extended out of the inner cavity, wherein the first hemostatic member can be folded under the pulling of the first traction line to fit the inner wall of the blood vessel at the puncture site;

[0011] A second hemostatic member, disposed in the inner cavity;

[0012] The second traction line has a first end fixed to the second hemostatic piece through the inner cavity and a second end extending out of the inner cavity. The second hemostatic piece can be folded to fit the outer surface of the blood vessel at the puncture site under the pulling of the second traction line.

[0013] Optionally, in the above-mentioned blood vessel occluding device, the support leg has a folding area at a middle position along the axial direction of the first hemostatic member, and the support leg can be folded along the folding area.

[0014] Optionally, in the above-mentioned vascular occluding device, a pull ring is provided on the first hemostatic piece, the first end of the second traction wire passes through the pull ring and is connected to an end of the second hemostatic piece away from the first hemostatic piece, and the second end of the second traction wire extends out of the inner cavity.

[0015] Optionally, the above-mentioned blood vessel occluding device further includes a locking buckle, which is arranged in the inner cavity, the second hemostatic member is located between the first hemostatic member and the locking buckle, and the first traction line and the second traction line both pass through the locking buckle.

[0016] Optionally, in the above-mentioned blood vessel occluding device, the second hemostatic member is a wavy structure formed by reciprocating folding of a sheet member, and the second hemostatic member is provided with a hole for the first traction line and the second traction line to pass through.

[0017] Optionally, in the above-mentioned blood vessel occluding device, each folding area of ​​the second hemostatic member has three holes arranged along the same straight line, the first traction line passes through the hole in the middle, and the holes at both ends of the hole in the middle are for the second traction line to pass through.

[0018] Optionally, in the above-mentioned blood vessel occlusion device, the locking buckle comprises:

[0019] a first buckle portion, through which the first traction line passes;

[0020] The second buckle portion is arranged on the outer side of the first buckle portion, the second traction line passes through the second buckle portion, and the second buckle portion is provided with a clamping portion capable of clamping the internal traction line.

[0021] Optionally, the above-mentioned blood vessel occluding device further includes a propulsion tube, which is slidably disposed in the inner cavity and is located on the side of the locking buckle away from the second hemostatic member, and the first traction line and the second traction line both pass through the propulsion tube.

[0022] Optionally, in the above-mentioned blood vessel occluding device, the clamping portion is a protrusion protruding inwardly.

[0023] Optionally, in the above-mentioned blood vessel occluding device, the first hemostatic member, the second hemostatic member, the first traction wire and the second traction wire are all made of biodegradable materials.

[0024] The blood vessel occluding device provided by the utility model, when in use, pushes the first hemostatic piece and the catheter into the patient's blood vessel so that the first hemostatic piece completely enters the blood vessel and reaches the blood vessel puncture site, tightens the first traction line so that the first hemostatic piece is folded and fits against the inner wall of the blood vessel at the puncture site, then draws out the catheter, tightens the second traction line so that the second hemostatic piece is folded and fits against the outer surface of the blood vessel at the puncture site, the second hemostatic piece cooperates with the first hemostatic piece to clamp the blood vessel puncture site in the middle to prevent blood from spraying out, then cuts off the excess traction line, and the first hemostatic piece and the second hemostatic piece remain in the patient's body.

[0025] The blood vessel occluding device provided by the utility model can shorten the hemostasis time and bed rest time, reduce the patient's pain and the intensity of medical care, has a simple structure, is easy to operate and process, and the first hemostatic component and the second hemostatic component cooperate to seal the blood vessel puncture site, with a good sealing effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] In order to more clearly illustrate the embodiments of the utility model or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the utility model. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0027] Figure 1 This is a schematic diagram of the structure of the blood vessel occlusion device disclosed in the embodiment of the utility model;

[0028] Figure 2 It is a front view of the blood vessel occlusion device disclosed in the embodiment of the utility model;

[0029] Figure 3 for Figure 2 A partial enlarged view of middle A;

[0030] Figure 4 Schematic diagram of the working state of the blood vessel occlusion device disclosed in the embodiment of the utility model Figure 1 ;

[0031] Figure 5 for Figure 4 A partial enlarged view of B in the middle;

[0032] Figure 6 Schematic diagram of the working state of the blood vessel occlusion device disclosed in the embodiment of the utility model Figure 2 ;

[0033] Figure 7 for Figure 6 A partial enlarged view of middle C;

[0034] Figure 8 It is a structural schematic diagram of the initial state of the first hemostatic member disclosed in the embodiment of the utility model;

[0035] Fig. 9 It is a front view of the initial state of the first hemostatic member disclosed in the embodiment of the utility model;

[0036] Fig.10 It is a structural schematic diagram of the first hemostatic member in a folded state disclosed in an embodiment of the utility model;

[0037] Fig.11 A front view of the first hemostatic member in a folded state disclosed in an embodiment of the utility model;

[0038] Fig.12 It is a structural schematic diagram of the initial state of the second hemostatic member disclosed in the embodiment of the utility model;

[0039] Fig.13 It is a front view of the initial state of the second hemostatic member disclosed in the embodiment of the utility model;

[0040] Fig.14 It is a structural schematic diagram of the second hemostatic member in a folded state disclosed in an embodiment of the utility model;

[0041] Fig.15 A front view of the second hemostatic member in a folded state disclosed in an embodiment of the utility model;

[0042] Fig.16 It is a structural schematic diagram of the locking buckle disclosed in the embodiment of the utility model;

[0043] Fig.17 It is a cross-sectional view of the locking buckle disclosed in the embodiment of the utility model.

[0044] Figure 1-Figure 17 The meanings of the various reference numerals in the figure are as follows:

[0045] 101 is a first hemostatic component, 1011 is a support leg, 102 is a catheter, 103 is a handle, 104 is a first traction line, 105 is a tensioning component, 106 is a second hemostatic component, 107 is a second traction line, 108 is a locking buckle, 1081 is a first buckle portion, 1082 is a second buckle portion, and 109 is a propulsion tube. DETAILED DESCRIPTION

[0046] The core of the utility model is to provide a blood vessel occluding device to shorten the hemostasis time and bed rest time, and alleviate the pain of the patient and the intensity of medical care.

[0047] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.

[0048] like Figure 2 As shown, the embodiment of the utility model discloses a blood vessel occluding device, including a first hemostatic member 101 , a catheter 102 , a first traction line 104 , a second hemostatic member 106 and a second traction line 107 .

[0049] The catheter 102 has an inner cavity, and the first hemostatic member 101 is disposed at one end of the catheter 102. Figure 8-Figure 11 As shown, in the blood vessel occluding device disclosed in the embodiment of the utility model, the first hemostatic piece 101 is a tubular structure with one end closed and the other end open, a hollow opening penetrating the wall thickness is provided on the outer wall of the first hemostatic piece 101, and a support leg 1011 is formed between two adjacent hollow openings, and the support leg 1011 can be folded when the two ends of the first hemostatic piece 101 are close to each other.

[0050] The first end of the first traction line 104 is fixed to the first hemostatic piece 101 through the inner cavity of the catheter 102, and the second end extends out of the inner cavity. By pulling the first traction line 104, the first hemostatic piece 101 can be folded to fit the inner wall of the blood vessel at the puncture site. The second hemostatic piece 106 is arranged in the inner cavity of the catheter 102, and the first end of the second traction line 107 is fixed to the second hemostatic piece 106 through the inner cavity of the catheter 102, and the second end extends out of the inner cavity. By pulling the second traction line 107, the second hemostatic piece 106 can be folded to fit the outer surface of the blood vessel at the puncture site. It should be noted that the specific structure of the second hemostatic piece 106 can be the same as that of the first hemostatic piece 101, or it can be different.

[0051] The blood vessel occluding device disclosed in the embodiment of the utility model has a chamfered or rounded corner at one end (closed end) of the first hemostat 101 away from the catheter 102 for easy entry into the blood vessel. When in use, the first hemostat 101 and the catheter 102 are pushed into the patient's blood vessel so that the first hemostat 101 completely enters the blood vessel and reaches the blood vessel puncture site. The first traction line 104 is tightened so that the first hemostat 101 is folded and fits the inner wall of the blood vessel at the puncture site. Then the catheter 102 is withdrawn and the second traction line 107 is tightened so that the second hemostat 106 is folded and fits the outer surface of the blood vessel at the blood vessel puncture site. The second hemostat 106 cooperates with the first hemostat 101 to clamp the blood vessel puncture site in the middle to prevent blood from spraying out. The first traction line 104 and the second traction line 107 exposed to the outside are cut off, and the first hemostat 101, the second hemostat 106 and part of the first traction line 104 and the second traction line 107 remain in the body. It should be noted that the length of the first hemostatic piece 101 after folding is greater than the wound at the puncture site, and the length of the second hemostatic piece 106 after folding is greater than the wound at the puncture site. In order to make the part remaining in the patient's body absorbable, the first hemostatic piece 101, the second hemostatic piece 106, the first traction line 104 and the second traction line 107 are all made of biodegradable materials, so that the patient is not easily infected. Preferably, the first hemostatic piece 101 is made of biodegradable magnesium alloy.

[0052] The blood vessel occluding device provided by the utility model can shorten the hemostasis time and bed rest time, reduce the patient's pain and the intensity of medical care, has a simple structure, is easy to operate and process, and the first hemostatic component 101 and the second hemostatic component 106 cooperate to seal the blood vessel puncture site, with a good sealing effect.

[0053] like Figure 1 As shown, in a specific embodiment of the utility model, a handle 103 and a tensioning member 105 are further included. Specifically, the handle 103 is arranged at the other end of the catheter 102, and the handle 103 is fixedly connected to the catheter 102. The second end of the first traction line 104 extends out of the handle 103 and is connected to the tensioning member 105; the second end of the second traction line 107 is fixedly connected to the handle 103, and the second traction line 107 can be pulled by pulling the handle 103. The first hemostatic member 101 can be folded and attached to the inner wall of the blood vessel at the puncture site through the tensioning member 105, and then the handle 103 is pulled to withdraw the catheter 102, and at the same time, the second traction line 107 is tightened, so that the second hemostatic member 106 is folded and attached to the outer surface of the blood vessel at the puncture site, and then the exposed first traction line 104 and second traction line 107 can be cut off. The setting of the tensioning member 105 facilitates tightening the first traction line 104, and the setting of the handle 103 facilitates tightening the second traction line 107, and the catheter 102 can be withdrawn at the same time, which is convenient for operation. The following embodiment is described by taking the handle 103 and the tensioning member 105 as an example.

[0054] In a specific embodiment of the present invention, the support leg 1011 has a folding area at the middle position along the axial direction of the first hemostatic member 101, and the support leg 1011 can be folded along the folding area. The first traction line 104 is connected to the center position of the closed end of the first hemostatic member 101, that is, the first traction line 104 extends along the axial direction of the first hemostatic member 101. The initial state of the first hemostatic member 101 is as follows: Figure 8 As shown in FIG. 1 , before entering the blood vessel puncture site, the leg 1011 is in an unfolded state. After entering the blood vessel puncture site, the first traction line 104 is tightened by the tensioning member 105, the first hemostatic member 101 is subjected to the axial tension of the first traction line 104, and the leg 1011 is folded along the folding area. The first hemostatic member 101 after folding is as shown in FIG. Fig.10 As shown, after folding, it is similar to an umbrella-shaped structure, which fits the inner wall of the blood vessel and can block the puncture of the blood vessel. In a specific embodiment of the utility model, the number of legs 1011 is 4, and the 4 legs 1011 are symmetrically arranged along the center point of the first hemostatic member 101. It should be noted that the specific number of legs 1011 can be determined according to actual needs, as long as it can play the role of blocking the puncture of the blood vessel.

[0055] like Figure 2-Figure 3 As shown, in the vascular occlusion device disclosed in the embodiment of the utility model, a pull ring is provided on the first hemostatic member 101, and the first end of the second traction line 107 passes through the pull ring and is connected to the end of the second hemostatic member 106 away from the first hemostatic member 101, and the second end of the second traction line 107 extends outward from the inner cavity. Therefore, by tightening the first traction line 105 and the second traction line 107 in the same direction, the first hemostatic member 101 and the second hemostatic member 106 can be folded.

[0056] like Figure 2-Figure 3 As shown, in order to make the second hemostatic member 106 pressed against the outer surface of the blood vessel, the blood vessel occlusion device disclosed in the embodiment of the utility model further includes a locking buckle 108. The locking buckle 108 is arranged in the inner cavity of the catheter 102, the second hemostatic member 106 is located between the first hemostatic member 101 and the locking buckle 108, and the first traction line 104 and the second traction line 107 both pass through the locking buckle 108. Figure 3 As shown, the first hemostatic member 101 is arranged at the far left, and the inside of the catheter 102 is provided with the second hemostatic member 106 and the locking buckle 108 from left to right. The locking buckle 108 can slide along the first traction line 104 and the second traction line 107 .

[0057] After the first hemostatic piece 101 is folded and fitted to the inner wall of the blood vessel at the puncture site, the handle 103 is pulled to withdraw the catheter 102, and the second traction line 107 is tightened at the same time, and the second hemostatic piece 106 is folded and fitted to the outer surface of the blood vessel at the puncture site, exposing the locking buckle 108, and the locking buckle 108 is pushed to move toward the second hemostatic piece 106 until it contacts the second hemostatic piece 106, and the second hemostatic piece 106 is pressed against the outer surface of the blood vessel to prevent the second traction line 107 from loosening. Figure 4-Figure 7 It should be noted that after the puncture site is blocked, the locking buckle 108 remains in the patient's body. The locking buckle 108 is made of biodegradable materials, specifically, absorbable iron, stainless steel, magnesium alloy, etc. The specific structure of the locking buckle 108 is not limited, as long as the locking buckle 108 is pressed tightly against the second hemostatic member 106.

[0058] like Figure 12-Figure 15 As shown, in the vascular occlusion device disclosed in the embodiment of the utility model, the second hemostatic member 106 is a wavy structure formed by reciprocating folding of a sheet member, and a hole is provided on the second hemostatic member 106 for the first traction line 104 and the second traction line 107 to pass through. It should be noted that the second hemostatic member 106 is made of a compressible, biodegradable material, such as a collagen pad made of a fibrous collagen mixture of insoluble and soluble collagen, and the collagen can be obtained from the connective tissue of animals, and the collagen can be purified from the subcutaneous layer of cowhide.

[0059] Figure 12-13 106 is a schematic diagram of the initial state of the second hemostatic member 106. The shape of the sheet is rectangular, and the second hemostatic member 106 is in an unfolded state. When in use, the second traction line 107 is tightened by pulling the handle 103, and the second hemostatic member 106 is folded. The schematic diagram of the folded state is as shown in FIG. Figure 14-15 The folded second hemostatic member 106 is attached to the outer surface of the blood vessel at the puncture site, and cooperates with the first hemostatic member 101 to sandwich the puncture site of the blood vessel and prevent blood from spraying out.

[0060] The second hemostatic element 106 is folded back and forth to form a plurality of folded areas, such as Fig.12 Six folding areas are formed, and the number of holes opened in each folding area includes three. The three holes are arranged along the same straight line. For the convenience of description, the three holes are the first hole, the second hole and the third hole from top to bottom. The first traction line 104 passes through the second hole, and the second traction line 107 passes through the first hole and the third hole. Figure 7 As shown, the second traction line 107 passes through the third hole on each sheet member from right to left in turn, then passes through the pull ring on the first hemostatic member 101, and then passes through the first hole on each sheet member from left to right in turn, and then the end point of the second traction line 107 is fixed to prevent the second traction line 107 from falling out of the hole.

[0061] like Figure 16-17 As shown, the locking buckle 108 disclosed in the embodiment of the utility model includes a first buckle portion 1081 and a second buckle portion 1082. Specifically, the first buckle portion 1081 is made of plastic and is a cylindrical structure, and the first traction line 104 passes through the first buckle portion 1081. The second buckle portion 1082 is a metal sheet, which is arranged on the outside of the first buckle portion 1081. Specifically, the second buckle portion 1082 can be fixed to the first buckle portion 1081 by welding or bonding. The second buckle portion 1082 includes a protruding portion for the second traction line 107 to pass through.

[0062] In order to make the second hemostatic member 106 pressed against the blood vessel wall, the blood vessel occlusion device disclosed in the embodiment of the utility model is provided with a clamping portion 1082 that can clamp the internal traction line. Specifically, the clamping portion is a protrusion protruding inward. Figure 16-17 As shown, the protrusions are distributed on both sides of the second buckle 1082 to better clamp the second traction line 107, and the number of protrusions can be multiple. During processing, the protruding parts can be squeezed by a pressing clamp to deform them and form protrusions on the inner wall to clamp the second traction line 107 to prevent the second traction line 107 from loosening in a natural state. It should be noted that the deformation process of the locking buckle 108 is carried out during the assembly process, and the locking buckle 108 is in a clamped state during use.

[0063] In order to facilitate pushing the locking buckle 108, Figure 2-Figure 3 As shown, in a specific embodiment of the present invention, a push tube 109 is also included. The push tube 109 is slidably disposed in the inner cavity and is located on the side of the locking buckle 108 away from the second hemostatic member 106. The first traction line 104 and the second traction line 107 both pass through the push tube 109. Figure 3 As shown, inside the catheter 102 , from left to right, there are a second hemostatic member 106 , a locking buckle 108 , and a pushing tube 109 . The locking buckle 108 and the pushing tube 109 can slide along the first traction line 104 and the second traction line 107 .

[0064] When in use, after the first hemostatic piece 101 is folded and fitted to the inner wall of the blood vessel at the puncture site, the handle 103 is pulled to withdraw the catheter 102, tighten the second traction line 107, and the second hemostatic piece 106 is folded and fitted to the outer surface of the blood vessel at the puncture site, exposing the locking buckle 108 and the pushing tube 109, and then the pushing tube 109 is pushed so that the pushing tube 109 contacts the locking buckle 108 and pushes the locking buckle 108 to move toward the second hemostatic piece 106 until it contacts the second hemostatic piece 106 and presses the second hemostatic piece 106 against the outer surface of the blood vessel to prevent the second traction line 107 from loosening. Figure 4-Figure 7In order to increase the friction during manual operation, concave points or lines are provided on the outer surface of the push tube 109. The setting of the push tube 109 facilitates pushing the locking buckle 108.

[0065] It should be noted that the various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.

[0066] As shown in this application and claims, unless the context clearly indicates an exception, the words "a", "an", "a kind" and / or "the" do not refer to the singular, but also include the plural. Generally speaking, the terms "include" and "comprise" only indicate the inclusion of clearly identified steps and elements, and these steps and elements do not constitute an exclusive list. The method or device may also include other steps or elements. The elements defined by the sentence "includes a..." do not exclude the existence of other identical elements in the process, method, commodity or device that includes the elements.

[0067] In the following, the terms "first" and "second" are used for descriptive purposes only and are not to be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the features.

[0068] This article uses specific examples to illustrate the principles and implementation methods of the utility model. The above examples are only used to help understand the core idea of ​​the utility model. It should be pointed out that for ordinary technicians in this technical field, without departing from the principle of the utility model, the utility model can also be improved and modified, and these improvements and modifications also fall within the scope of protection of the claims of the utility model.

Claims

1. A blood vessel occlusion device, characterized in that: include: A catheter (102) having an inner lumen; A first hemostatic member (101) is arranged at one end of the catheter (102), the first hemostatic member (101) is a tubular structure with one end closed and the other end open, and a hollow opening penetrating the wall thickness is provided on the outer wall of the first hemostatic member (101), and a support leg (1011) is formed between two adjacent hollow openings, and the support leg (1011) can be folded when the two ends of the first hemostatic member (101) are close to each other; A first traction line (104), a first end of which is fixed to the first hemostatic element (101) through the inner cavity, and a second end of which extends out of the inner cavity, and the first hemostatic element (101) can be folded under the pull of the first traction line (104) to fit the inner wall of the blood vessel at the puncture site; A second hemostatic member (106) is disposed in the inner cavity; A second traction line (107) has a first end fixed to the second hemostatic piece (106) through the inner cavity and a second end extending out of the inner cavity. The second hemostatic piece (106) can be folded under the pulling of the second traction line (107) to fit the outer surface of the blood vessel at the puncture site.

2. The vascular occlusion device according to claim 1, characterized in that: The support leg (1011) has a folding area at a middle position along the axial direction of the first hemostatic member (101), and the support leg (1011) can be folded along the folding area.

3. The vascular occlusion device according to claim 2, characterized in that: The first hemostatic piece (101) is provided with a pull ring, and the first end of the second traction line (107) passes through the pull ring and is connected to an end of the second hemostatic piece (106) away from the first hemostatic piece (101), and the second end of the second traction line (107) extends out of the inner cavity.

4. The blood vessel occlusion device according to claim 1, characterized in that: It also includes a locking buckle (108), which is arranged in the inner cavity, the second hemostatic component (106) is located between the first hemostatic component (101) and the locking buckle (108), and the first traction line (104) and the second traction line (107) both pass through the locking buckle (108).

5. The blood vessel occluding device according to claim 4, characterized in that: The second hemostatic member (106) is a wave-like structure formed by reciprocating folding of a sheet-like member, and the second hemostatic member (106) is provided with a hole for the first traction line (104) and the second traction line (107) to pass through.

6. The blood vessel occluding device according to claim 5, characterized in that: The holes opened on each folding area of ​​the second hemostatic member (106) include three holes arranged along the same straight line, the first traction line (104) passes through the hole located in the middle position, and the holes at both ends of the hole located in the middle position are for the second traction line (107) to pass through.

7. The blood vessel occluding device according to claim 4, characterized in that: The locking buckle (108) comprises: A first buckle portion (1081), wherein the first traction line (104) passes through the first buckle portion (1081); The second buckle portion (1082) is arranged on the outer side of the first buckle portion (1081), the second traction line (107) passes through the second buckle portion (1082), and the second buckle portion (1082) is provided with a clamping portion capable of clamping the internal traction line.

8. The blood vessel occluding device according to claim 7, characterized in that: The clamping portion is a protrusion protruding inwardly.

9. The blood vessel occluding device according to claim 4, characterized in that: It also includes a propulsion tube (109), which is slidably disposed in the inner cavity and is located on a side of the locking buckle (108) away from the second hemostatic component (106), and the first traction line (104) and the second traction line (107) both pass through the propulsion tube (109).

10. The blood vessel occluding device according to any one of claims 1 to 9, characterized in that: The first hemostatic element (101), the second hemostatic element (106), the first traction line (104) and the second traction line (107) are all made of biodegradable materials.